Search
for
Sort by
Research 121–150 of 1000+
- Advances in Bioprinting to Model Immune‐Mediated Skin Diseases
- Alopecia Areata in Latin America: Where are We and Where are We Going?
- Biliary fibrosis is an important but neglected pathological feature in hepatobiliary disorders: from molecular mechanisms to clinical implications
- Lysophospholipid Mediators in Health and Disease
- Challenges, Progress, and Prospects of Developing Therapies to Treat Autoimmune Diseases
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- Serum level of interleukin-15 in active alopecia areata patients and its relation to age, sex, and disease severity
- Aberrant inflammasome activation as a driving force of human autoimmune skin disease
- Increase in IL-15 levels in patients with alopecia areata
- Teriflunomide (Aubagio®) for the treatment of multiple sclerosis
- The Potential Application of Exosomes as Therapeutic Agents, Carriers, and Biomarkers in Skin Diseases
- Noval advance of histone modification in inflammatory skin diseases and related treatment methods
- Hair Follicle Immune Privilege Revisited: The Key to Alopecia Areata Management
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article
- Dental Rehabilitation of a Child Diagnosed With Alopecia Areata Totalis: A Case Report
- Traditional and Integrative Approaches to the Treatment of Alopecia
- Differential impact of environmental factors on systemic and localized autoimmunity
- Early prediction of alopecia areata using machine learning modeling of neuro stress immune signatures from multi datasets
- Longitudinal clinical course, treatment outcomes, and relapse patterns in alopecia areata: a prospective cohort study
- The Use of 308-nm Excimer Laser Therapy in Alopecia Areata and Primary Cicatricial Alopecia: A Systematic Review
- Assessment of vitamin D levels in patients with alopecia areata: a case-control study in a Tertiary Care Hospital in North India
- Tru9I Variant as a Novel Genetic Marker for Vitamin D Deficiency in Alopecia Areata
- Gene Expression of CD70 and CD27 Is Increased in Alopecia Areata Lesions and Associated with Disease Severity and Activity
- Immune therapies for alopecia areata: evidence and new perspectives
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Selective Expression of Chemokine Monokine Induced by Interferon-γ in Alopecia Areata
- Elevated serum heat shock protein-70 and interleukin-15: prognostic biomarkers correlating with clinical severity and diagnostic efficacy in active alopecia areata
- Vaccines, adjuvants and autoimmunity
- Baricitinib Effectiveness in JAKi‐Naïve and Tofacitinib‐Exposed Patients: A Prospective Study in Alopecia Areata
- Dietary Habits in Japanese Patients with Alopecia Areata